← Leaderboards
Maen Abdelrahim
Texas A&M University
$566,889
Attributed
$1,700,667
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $585.6K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,700,667 · 1
By mechanism
R01$1,700,667 · 1
Top collaborators
- James Jing Cai3 shared
- Stephen H Safe3 shared
Most similar at Texas A&M University
Same institution · by research overlap
- Stephen H Safe$17,757,115
- James Jing Cai$758,576
Others in their field
Other Rising Stars on “Alcohol Consumption”
- Charles Daniel Meyers · Tempero Bio, Inc.$5,310,920
- Emorie Danielle Beck · University Of California At Davis$3,424,229
- Cindy Ann Burklow · Naprogenix, Inc$3,364,723
- Farshad Tehrani · Actiox Llc$3,301,618
- Neha John-Henderson · Montana State University - Bozeman$3,209,786
- Myra Elizabeth Parker · Americans For Indian Opportunity$2,670,052
Research focus
Alcohol ConsumptionAngiogenesisAntagonistAntibodiesBindingCancer CellCancer DiagnosisCapecitabineCell Culture TechniquesCell GrowthCellsCessation Of LifeChemopreventive AgentChemotherapeutic AgentChemotherapyChemotherapy-Oncologic ProcedureClinical ApplicationColonColon Cancer PatientsColon CarcinomaColonic NeoplasmsColorectal CancerColorectal Cancer TreatmentAffinity
Grant awards (3)
NR4A1 Antagonists Inhibit Colorectal Cancer Growth and Enhance Immune Surveillance$571,380
R01 · FY2025 · CA
NR4A1 Antagonists Inhibit Colorectal Cancer Growth and Enhance Immune Surveillance$543,717
R01 · FY2024 · CA
NR4A1 Antagonists Inhibit Colorectal Cancer Growth and Enhance Immune Surveillance$585,570
R01 · FY2023 · CA